Lightcast Discovery: Funding, Investors & Team (Sep 2026)
Lightcast utilizes a microfluidic system to make progress in unconventional medical techniques, novel treatments, and cutting-edge merchandise. The primary goal of the company is to push the limits of intricate cellular analysis. Through the employment of the Lightcast platform, the company collaborates with prominent pharmaceutical organizations and top-notch educational institutions in order to facilitate their exploration. The Lightcast system allows for precise and remarkably adaptable independent regulation of numerous droplets. By combining droplets containing diverse cells, reporters, or other substances, we are able to execute complex processes without the manual manipulation of cells. Cameron Frayling established Lightcast Discovery in 2019.
Lightcast Discovery has raised $75.3M across 2 funding rounds on record, the most recent an undisclosed round of $27.0M announced in Apr 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Lightcast Discovery Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Lightcast Discovery Funding Rounds
Lightcast Discovery raised $48.3M in a Series B announced in Aug 2023.
2.7 years later, an undisclosed round of $27.0M was announced in Apr 2026.
Lightcast Discovery Founders and Leadership Team
Contact details for the Lightcast Discovery team: 1 of 2 have an email address on file.
Start 14-day free trial →Lightcast Discovery Funding Compared to Other Biotechnology Startups
Lightcast Discovery's latest round of $27.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lightcast Discovery in Biotechnology and Cambridge
Companies Similar to Lightcast Discovery
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Lightcast Discovery Funding FAQs
What does Lightcast Discovery do?
Lightcast utilizes a microfluidic system to make progress in unconventional medical techniques, novel treatments, and cutting-edge merchandise. The primary goal of the company is to push the limits of intricate cellular analysis. Through the employment of the Lightcast platform, the company collaborates with prominent pharmaceutical organizations and top-notch educational institutions in order to facilitate their exploration. The Lightcast system allows for precise and remarkably adaptable independent regulation of numerous droplets. By combining droplets containing diverse cells, reporters, or other substances, we are able to execute complex processes without the manual manipulation of cells. Cameron Frayling established Lightcast Discovery in 2019.
How much funding has Lightcast Discovery raised?
Lightcast Discovery has raised $75.3M across 2 rounds on record. The most recent is an undisclosed round of $27.0M announced in Apr 2026.
When did Lightcast Discovery last raise funding?
Lightcast Discovery's most recent funding round on record is an undisclosed round of $27.0M, announced in Apr 2026.
Who founded Lightcast Discovery?
FundedIQ lists Paul Loeffen (Founder) at Lightcast Discovery.
Who is the CEO of Lightcast Discovery?
Cameron Frayling is listed as CEO at Lightcast Discovery.
Where is Lightcast Discovery headquartered?
Lightcast Discovery is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does Lightcast Discovery have?
Lightcast Discovery is in the 51-100 employee band.
How does Lightcast Discovery's funding compare to other Biotechnology startups?
Lightcast Discovery's latest round of $27.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Lightcast Discovery Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lightcast Discovery is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.